Shares of Amryt Pharma plc (LON:AMYT – Get Free Report) crossed above its 50-day moving average during trading on Thursday . The stock has a 50-day moving average of GBX 143 ($1.91) and traded as high as GBX 155 ($2.08). Amryt Pharma shares last traded at GBX 143 ($1.91), with a volume of 90,726 shares trading hands.
Amryt Pharma Price Performance
The stock has a market cap of £457.11 million and a P/E ratio of -4.33. The company’s fifty day moving average price is GBX 143 and its 200-day moving average price is GBX 143. The company has a debt-to-equity ratio of 66.05, a quick ratio of 1.14 and a current ratio of 1.80.
About Amryt Pharma
Amryt Pharma plc, a commercial-stage biopharmaceutical company, develops and commercializes novel therapeutics to treat patients suffering from serious and life-threatening rare diseases. The company offers Lomitapide for the treatment of homozygous familial hypercholesterolemia; and Metreleptin for the treatment of generalized and partial lipodystrophy.
Read More
- Five stocks we like better than Amryt Pharma
- 3 Fintech Stocks With Good 2021 Prospects
- CarMax’s Impressive Rally: What Investors Should Watch Next
- 3 Natural Gas Stocks That Offer Great Dividend Yields
- MarketBeat Week in Review – 9/23 – 9/27
- What Investors Need to Know to Beat the Market
- Wake Up to This Biotech Stock That Still Has Big Potential Upside
Receive News & Ratings for Amryt Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amryt Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
